Gut microbiome as a predictor of long-term abdominal outcomes of COVID-19
Russian Family Doctor · 30.09.2026 · 30 (3) · 5-14
DOI: 10.17816/rfd716730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Russian Family Doctor, online erschienen am 30.09.2026. Verfasst von Nina I. Zhernakova und 2 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Post-COVID syndrome with persistent abdominal disorders is a significant medical and social problem, but the prognostic criteria for the development of chronic intestinal dysfunction are not sufficiently systematized. This review substantiates the concept of the intestinal microbiome as a promising integral predictive marker for the long-term gastrointestinal outcomes of COVID-19. Based on the analysis of 40 sources using the PRISMA methodology, the pathogenetic mechanisms of virus-induced dysbiosis have been systematized, including the blockade of the APF2–B⁰AT1 (sodium-dependent neutral amino acid transporter B(0)AT1, SLC6A19) complex, tryptophan deficiency, and inhibition of short-chain fatty acid production. It has been shown that the characteristic taxonomic shifts—a decrease in Faecalibacterium prausnitzii, Bifidobacterium spp., and Bacteroides spp., and an expansion of Ruminococcus gnavus and Enterococcus spp.— persist for more than 12 months and correlate with the frequency of post-COVID irritable bowel syndrome. Quantitative threshold predictive values have been determined: F. prausnitzii below 105 CFU/g, calprotectin above 100 μg/g, Shannon index less than 3.0. Three prognostic trajectories of microbiota recovery (restorative, stable-dysbiotic, and late dysbiotic) have been identified, and differential diagnostic microbiome patterns that distinguish post-COVID irritable bowel syndrome from the onset of inflammatory bowel diseases have been presented. A practical algorithm for monitoring convalescents has been substantiated, including early screening on day 30, risk stratification, and targeted correction (calcium butyrate, synbiotics).
Zitieren
APA
Zhernakova, N. I., Zherdeva, A. A., & Popova, N. V. (2026). Gut microbiome as a predictor of long-term abdominal outcomes of COVID-19. Russian Family Doctor, 30(3), 5-14. https://doi.org/10.17816/rfd716730
Vancouver
Zhernakova NI, Zherdeva AA, Popova NV. Gut microbiome as a predictor of long-term abdominal outcomes of COVID-19. Russian Family Doctor. 2026;30(3):5-14. doi:10.17816/rfd716730
BibTeX
@article{Zhernakova2026,
author = {Zhernakova, Nina I. and Zherdeva, Arina A. and Popova, Natalia V.},
title = {Gut microbiome as a predictor of long-term abdominal outcomes of COVID-19},
journal = {Russian Family Doctor},
year = {2026},
volume = {30},
number = {3},
pages = {5--14},
doi = {10.17816/rfd716730}
}
EUVIMED